Six-month prospective study to monitor the treatment of rheumatic diseases with sustained-release flurbiprofen

Drugs under Experimental and Clinical Research

Volumn 26, Issue 1, 2000, Pages 19-24

  Rovensky J ^a   Micekova D ^a  

^a NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

FLURBIPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL TRIAL; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SLOVAKIA;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; DELAYED-ACTION PREPARATIONS; FEMALE; FLURBIPROFEN; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PROSPECTIVE STUDIES; SPONDYLITIS, ANKYLOSING;

EID: 0343293985     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Stubbs D.E., Freeman B.E. Efficacy comparisons of flurbiprofen and other non-steroidal anti-inflammatory drugs in arthritic disease. Curr. Ther. Res., 46, 511, 1989.
2. Donovan S., Higgins C.H., Saunders C.A., Olejárová M., Pavelka K. Comparison of success criteria for flurbiprofen in the treatment of some rheumatological diseases. Čes. Revmatol., 2, 78, 1996 (in Czech).
3. Boston P.E., Constad D. A general practice study ot flurbiprofen sustained-release. Brit. J. Clin. Pract., 42, 3, 1988.
4. Huskinsson E.C., Ghozlan R., Kurthen R., et al. A long-term study to evaluate the safety and efficacy of meloxicam therapy in the patients with rheumatoid arthritis. Brit. J. Rheumatol., 35, 29, 1996.
5. Scholes D., Stergachis A., Penna P.M., et al. Non-steroidal anti-inflammatory drug discontinuation in patients with osteoarthritis. J. Rheumatol., 22, 708, 1995.
6. Jones C.W. A post-marketing surveillance study of Voltarol 75 mg SR in the primary care setting. Brit. J. Clin. Pract., 50, 390, 1996.
7. Ghozlan R., Laborde C., Courcier S. Tolerability, efficacy and quality of live evaluation of sustained-release flurbiprofen (Cebutid LP) in osteoarthritis of the hip and knee. A study by French rheumatologists (abstract). Brit. J. Rheumatol., 161, 2, 1992.
8. Haanen H.C.M., De Nayer J., Vlolles P.W., Tebbs V.M. Efficacy and tolerability of sustained-release fluroiprofen (Froben SR, Froben Suscap) in arthritis: General practice studies in the UK and Holland (abstract). Brit. J, Rheumatol., 31, 2, 1992.
9. Kool J., Naberr F.R., Meindersma J., Aldwinckle T.J. Efficacy and tolerability of sustained-release flurbiprofen (Froben SR, Froben Suscaps) in arthritis: General practice studies in the UK and Holland. Brit. J. Rheumatol., 31, 160, 1992 (abstract 104).
10. Sheldrake E.E., Webber J.M., Marsh B.D. A long-term assessment of flurbiprofen. Curr. Med. Res. Opinion, 5, 106, 1977.
11. Busson M. A long-term study of flurbiprofen in rheumatological disorders. I. Rheumatoid arthritis. J. Int. Med, Res., 14, 1, 1986.
12. Busson M. A long-term study of flurbiprofen in rheumatological disorders. II. Osteoarthritis. J. Int. Med, Res., 14, 7, 1986.
13. Busson M. A long-term study of flurbiprofen in rheumatological disorders. III. Other articular conditions. J, Int. Med. Res., 14, 13, 1986.
14. Anderson M., Bedi S.S., Boston P.F, et al. A long-term study of flurbiprofen sustained-release. Brit. J. Clin. Pract , 42, 215, 1988.